CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...